Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy

Journal of Cellular Biochemistry

Volumn 108, Issue 3, 2009, Pages 537-546

  Coutu, Daniel L ^a   Yousefi, Azizeh Mitra ^b   Galipeau, Jacques ^c  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

3D porous scaffolds; Adult stem cells; Biomaterials; Cell therapy; Gene therapy; Tissue engineering

Indexed keywords

ALUMINUM OXIDE; BIOMATERIAL; CALCIUM PHOSPHATE; FIBRIN; FIBRONECTIN; HYDROXYAPATITE; POLY(LACTIC CO GLYCOLIC ACID); POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; TETRACALCIUM PHOSPHATE; THREE DIMENSIONAL POROUS SCAFFOLD; UNCLASSIFIED DRUG;

ADULT; CARDIOVASCULAR DISEASE; CASE REPORT; CELL BASED GENE THERAPY; COMPUTER ANALYSIS; HUMAN; LIVER DISEASE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; GENE THERAPY; HUMANS; POROSITY; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

HARNESS;

EID: 70350167107     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22296     Document Type: Review

References (49)

1. Arumuganathar S, Jayasinghe SN. 2008. Living scaffolds (specialized and unspecialized) for regenerative and therapeutic medicine. Biomacromolecules 9:759-766. (Pubitemid 351560463)
2. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. 2003. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776. (Pubitemid 37186770)
3. Borenstein JT, Weinberg EJ, Orrick BK, Sundback C, Kaazempur-Mofrad MR, Vacanti JP. 2007. Microfabrication of three-dimensional engineered scaffolds. Tissue Eng 13:1837-1844.
4. Brunetti-Pierri N, Lee B. 2005. Gene therapy for inborn errors of liver metabolism. Mol Genet Metab 86:13-24. (Pubitemid 41412158)
5. Cancedda R, Giannoni P, Mastrogiacomo M. 2007. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 28:4240-4250. (Pubitemid 47212405)
6. Caplan AI. 2009. Why are MSCs therapeutic? New data: New insight. J Pathol 217:318-324.
7. Chang PL. 1999. Encapsulation for somatic gene therapy. Ann N Y Acad Sci 875:146-158.
8. Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT. 2005. Custom design of the cardiac microenvironment with biomaterials. Circ Res 97:8-15.
9. Desnick RJ, Schuchman EH. 2002. Enzyme replacement and enhancement therapies: Lessons from lysosomal disorders. Nat Rev Genet 3:954-966.
10. Duncan AW, Dorrell C, Grompe M. 2009. Stem cells and liver regeneration. Gastroenterology (in press).
11. Edelstein ML, Abedi MR, Wixon J. 2007. Gene therapy clinical trials worldwide to 2007 - An update. J Gene Med 9:833-842. (Pubitemid 47543250)
12. Engler AJ, Sen S, Sweeney HL, Discher DE. 2006. Matrix elasticity directs stem cell lineage specification. Cell 126:677-689. (Pubitemid 44233625)
13. Fiegel HC, Kaufmann PM, Bruns H, Kluth D, Horch RE, Vacanti JP, Kneser U. 2008. Hepatic tissue engineering: From transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med 12:56-66.
14. Gamradt SC, Lieberman JR. 2004. Genetic modification of stem cells to enhance bone repair. Ann Biomed Eng 32:136-147.
15. Garcia-Martin C, Chuah MK, Van Damme A, Robinson KE, Vanzieleghem B, Saint-Remy JM, Gallardo D, Ofosu FA, VandenDriessche T, Hortelano G. 2002. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: Potential for gene therapy of haemophilia A. J Gene Med 4:215-223. (Pubitemid 40277171)
16. Griffith LG. 2002. Emerging design principles in biomaterials and scaffolds for tissue engineering. Ann N Y Acad Sci 961:83-95. (Pubitemid 34721746)
17. Hoganson DM, Pryor HI, Vacanti JP. 2008. Tissue engineering and organ structure: A vascularized approach to liver and lung. Pediatr Res 63:520-526.
18. Hollister SJ. 2005. Porous scaffold design for tissue engineering. Nat Mater 4:518-524. (Pubitemid 40952745)
19. Hortelano G, Wang L, Xu N, Ofosu FA. 2001. Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: Concurrent tumourigenesis. Haemophilia 7:207-214. (Pubitemid 32243804)
20. Hsu SH, Su CH, Chiu IM. 2009. A novel approach to align adult neural stem cells on micropatterned conduits for peripheral nerve regeneration: A feasibility study. Artif Organs 33:26-35.
21. Jawad H, Ali NN, Lyon AR, Chen QZ, Harding SE, Boccaccini AR. 2007. Myocardial tissue engineering: A review. J Tissue Eng Regen Med 1:327-342.
22. Krebsbach PH, Zhang K, Malik AK, Kurachi K. 2003. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: Human factor IX model. J Gene Med 5:11-17. (Pubitemid 40310363)
23. Laflamme MA, Murry CE. 2005. Regenerating the heart. Nat Biotechnol 23:845-856.
24. Lillicrap D, VandenDriessche T, High K. 2006. Cellular and genetic therapies for haemophilia. Haemophilia 12(Suppl 3): 36-41.
25. Mano JF, Silva GA, Azevedo HS, Malafaya PB, Sousa RA, Silva SS, Boesel LF, Oliveira JM, Santos TC, Marques AP, Neves NM, Reis RL. 2007. Natural origin biodegradable systems in tissue engineering and regenerative medicine: Present status and some moving trends. J R Soc Interface 4:999-1030.
26. Martinez E, Engel E, Planell JA, Samitier J. 2009. Effects of artificial microand nano-structured surfaces on cell behaviour. Ann Anat 191:126-135.
27. Matsui H, Shibata M, Brown B, Labelle A, Hegadorn C, Andrews C, Hebbel RP, Galipeau J, Hough C, Lillicrap D. 2007. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors. Stem Cells 25:2660-2669. (Pubitemid 47582759)
28. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. 2004. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6:483-495. (Pubitemid 38456178)
29. Murphy SL, High KA. 2008. Gene therapy for haemophilia. Br J Haematol 140:479-487.
30. Muschler GF, Nakamoto C, Griffith LG. 2004. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86-A:1541-1558. (Pubitemid 38886548)
31. Nathwani AC, Davidoff AM, Linch DC. 2005. A review of gene therapy for haematological disorders. Br J Haematol 128:3-17.
32. Ohgushi H, Caplan AI. 1999. Stem cell technology and bioceramics: From cell to gene engineering. J Biomed Mater Res 48:913-927.
33. Porteus MH, Connelly JP, Pruett SM. 2006. A look to future directions in gene therapy research for monogenic diseases. PLoS Genet 2:e133.
34. Potter W, Kalil RE, Kao WJ. 2008. Biomimetic material systems for neural progenitor cell-based therapy. Front Biosci 13:806-821. (Pubitemid 351594730)
35. Prockop DJ. 2007. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther 82:241-243.
36. Prockop DJ, Olson SD. 2007. Clinical trials with adult stem/progenitor cells for tissue repair: Let's not overlook some essential precautions. Blood 109:3147-3151.
37. Pryor HI, Vacanti JP. 2008. The promise of artificial liver replacement. Front Biosci 13:2140-2159.
38. Roth DA, Tawa NE, Jr., O'Brien JM, Treco DA, Selden RF. 2001. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N Engl J Med 344:1735-1742. (Pubitemid 32497027)
39. Sachlos E, Czernuszka JT. 2003. Making tissue engineering scaffolds work. Review: The application of solid freeform fabrication technology to the production of tissue engineering scaffolds. Eur Cell Mater 5:29-39.
40. Sands MS, Davidson BL. 2006. Gene therapy for lysosomal storage diseases. Mol Ther 13:839-849.
41. Scime A, Caron AZ, Grenier G. 2009. Advances in myogenic cell transplantation and skeletal muscle tissue engineering. Front Biosci 14:3012-3023.
42. Segers VF, Lee RT. 2008. Stem-cell therapy for cardiac disease. Nature 451:937-942.
43. Srouji S, Kizhner T, Livne E. 2006. 3D scaffolds for bone marrow stem cell support in bone repair. Regen Med 1:519-528.
44. Teixeira AI, Duckworth JK, Hermanson O. 2007. Getting the right stuff: Controlling neural stem cell state and fate in vivo and in vitro with biomaterials. Cell Res 17:56-61. (Pubitemid 46096425)
45. Thomas CE, Ehrhardt A, Kay MA. 2003. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346-358. (Pubitemid 36538359)
46. Thorrez L, Vandenburgh H, Callewaert N, Mertens N, Shansky J, Wang L, Arnout J, Collen D, Chuah M, VandenDriessche T. 2006. Angiogenesis enhances factor IX delivery and persistence from retrievable human bioengineered muscle implants. Mol Ther 14:442-451. (Pubitemid 44184960)
47. Thorrez L, Shansky J, Wang L, Fast L, VandenDriessche T, Chuah M, Mooney D, Vandenburgh H. 2008. Growth, differentiation, transplantation and survival of human skeletal myofibers on biodegradable scaffolds. Biomaterials 29:75-84. (Pubitemid 47599658)
48. Yang S, Leong KF, Du Z, Chua CK. 2001. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng 7:679-689.
49. Yang S, Leong KF, Du Z, Chua CK. 2002. The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Eng 8:1-11.